Atlas Trials

Severe Influenza Trial of ARbidol

Clinical trial NCT03787459 · COMPLETED

Trial details

NCT number
NCT03787459
Sponsor
Capital Medical University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza
Start date
2019-01-18
Primary completion
2023-04-09
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.